BusinessRemedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory BoardBy Nasdaq OMXFeb 12, 2018, 3:00 PM UTC
BusinessQ Therapeutics Announces Research Collaboration With REPROCELLBy Nasdaq OMXDec 13, 2017, 12:00 PM UTC
BusinessReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to TrialBy Nasdaq OMXNov 7, 2017, 6:00 PM UTC
BusinessLeading Spinal Cord Injury Experts Join ReNetX Scientific Advisory BoardBy Nasdaq OMXOct 10, 2017, 6:15 PM UTC
